Novel Surrogate Markers of CNS Inflammation in CSF in the Diagnosis of Autoimmune Encephalitis
| Autor: | Jocelyn X. Jiang, Nicole Fewings, Suat Dervish, Alessandro F. Fois, Stephen R. Duma, Matthew Silsby, Sushil Bandodkar, Sudarshini Ramanathan, Andrew Bleasel, Bryne John, David A. Brown, Ming-Wei Lin |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
diagnostic investigations
medicine.medical_specialty Neurology Movement disorders CSF surrogate markers cerebrospinal fluid lcsh:RC346-429 03 medical and health sciences 0302 clinical medicine Cerebrospinal fluid Monocytosis medicine lcsh:Neurology. Diseases of the nervous system Autoimmune encephalitis business.industry Surrogate endpoint Autoantibody Brief Research Report medicine.disease autoimmune encephalitis cytokines inflammation 030220 oncology & carcinogenesis Immunology Neurology (clinical) medicine.symptom business 030217 neurology & neurosurgery Encephalitis |
| Zdroj: | Frontiers in Neurology, Vol 10 (2020) Frontiers in Neurology |
| ISSN: | 1664-2295 |
| DOI: | 10.3389/fneur.2019.01390/full |
| Popis: | Background: Autoimmune encephalitis (AE) is an important cause of refractory epilepsy, rapidly progressive cognitive decline, and unexplained movement disorders in adults. Whilst there is identification of an increasing number of associated autoantibodies, patients remain with a high clinical probability of autoimmune encephalitis but no associated characterized autoantibody. These patients represent a diagnostic and treatment dilemma. Objective: To evaluate routine and novel diagnostic tests of cerebrospinal fluid (CSF) in patients with a high probability of AE to attempt to identify better biomarkers of neuroinflammation. Methods: Over 18 months (2016-2018), adult patients with a high clinical probability of AE were recruited for a pilot cross-sectional explorative study. We also included viral polymerase-chain-reaction (PCR) positive CSF samples and CSF from neurology patients with "non-inflammatory" (NI) diagnoses for comparison. CSF was examined with standard investigations for encephalitis and novel markers (CSF light chains, and cytokines). Results and Conclusions: Thirty-two AE patients were recruited over 18 months. Twenty-one viral controls, 10 NI controls, and five other autoimmune neurological disease controls (AOND) were also included in the analysis. Our study found that conventional markers: presence of CSF monocytosis, oligoclonal bands, anti-neuronal immunofluorescence, and magnetic resonance imaging (MRI) changes could be suggestive of AE, but these investigations were neither sensitive nor specific. Promising novel makers of autoimmune encephalitis were the CSF cytokines IL-21 and IP10 which may provide better delineation between viral infections and autoimmune encephalitis than conventional markers, potentially leading to more immediate diagnosis and management of these patients. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|